NCT05246254

Brief Summary

Several studies have shown that frailty can be used as a marker for risk of adverse outcomes in elderly patients such as falls, disability, hospitalization, mortality, and can be used to predict patient clinical outcomes. The purpose of this study is to determine whether preoperative frailty can be used as a diagnostic and predictive factor for postoperative delirium in elderly patients with hip fracture.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2022

Completed
20 days until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 18, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

October 31, 2023

Status Verified

February 1, 2023

Enrollment Period

2.9 years

First QC Date

January 12, 2022

Last Update Submit

October 30, 2023

Conditions

Keywords

frailtypostoperative deliriumhip fractureelderly

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative delirium(POD) in elderly patients with hip fracture

    The percentage of the study population who developed delirium within seven days of surgery,postoperative delirium(POD) is defined according to the CAM criterion

    Postoperative 7 days

Secondary Outcomes (7)

  • Duration of delirium

    Postoperative 7 days

  • Delirium drug use

    Postoperative 7 days

  • Length of hospital stay (HLOS)

    Postoperative 30 days

  • Length of ICU stay

    Postoperative 30 days

  • Hospital cost

    Postoperative 30 days

  • +2 more secondary outcomes

Study Arms (3)

Prefrailty group

According to the frailty index(FI) and FI =0.12\~0.25

Diagnostic Test: Frailty index scale

Frailty group

According to the frailty index(FI) and FI≥ 0.25

Diagnostic Test: Frailty index scale

Nonfrailty group

According to the frailty index(FI) and FI\<0.12

Diagnostic Test: Frailty index scale

Interventions

Frailty index scaleDIAGNOSTIC_TEST

There are clinically common scales for assessing weakness and delirium.

Also known as: CAM scale, Nu-DESC sclae
Frailty groupNonfrailty groupPrefrailty group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients over the age of 65 who underwent surgery for hip fractures

You may qualify if:

  • The subjects were patients with hip fracture;
  • Older than 65 years;
  • Patients signed informed consent;
  • American Society of Anesthesiologist (ASA) Rated I- III;
  • The surgery was performed by the same anesthesia and surgical team.

You may not qualify if:

  • Patients cannot sign the consent form or refuse to participate;
  • A history of cognitive impairment;
  • Unable to complete the cognitive function test;
  • Mental disorder during initial assessment;
  • Patients suffering from mental illness or substance use disorder;
  • Incomplete or lost data during follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tsinghua Changgung Hospital

Beijing, Beijing Municipality, 100018, China

RECRUITING

MeSH Terms

Conditions

FrailtyEmergence DeliriumHip Fractures

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsDeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsSigns and SymptomsNeurocognitive DisordersMental DisordersFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Huan Zhang, PhD

    Beijing Tsinghua Changgeng Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2022

First Posted

February 18, 2022

Study Start

February 1, 2022

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

October 31, 2023

Record last verified: 2023-02

Locations